Skip to Main Content

Paper Details

Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy.
J Am Heart Assoc
0
2023
Author NameAffiliation
Kevin F KennedySaint Luke's Mid America Heart Institute Kansas City MO USA.
Daniel J FriedmanDepartment of Medicine Duke University Medical Center Durham NC USA.
Daniel J FriedmanDuke Clinical Research Institute Durham NC USA.
  • 1 - 3

Datasets

Release 1.2